Long-term outcomes Long-term outcomes in patients with leucine-rich glioma inactivated-1 (LGI1) autoimmune encephalitis are a …
Category:
Headaches
-
-
Headaches
Comparative Analysis of CGRP, VIP and PACAP-38 Levels in Migraine with and Without Aura: A Case-control Study
by myneuronewsby myneuronewsStudy Overview This research investigates the levels of three neuropeptides—CGRP (Calcitonin Gene-Related Peptide), VIP (Vasoactive …
-
Headaches
Painful symptoms and spine-specific activity limitations associated with dural ectasia in individuals with Marfan syndrome: a cross-sectional comparative study (MARFANLOMB)
by myneuronewsby myneuronewsDural Ectasia in Marfan Syndrome Dural ectasia refers to the abnormal dilation of the dura …
-
Headaches
Human Herpesvirus-6 Infectious Meningitis With Lymphadenitis in an Immunocompetent Adult
by myneuronewsby myneuronewsStudy Overview This research explored a case involving Human Herpesvirus-6 (HHV-6) leading to infectious meningitis …
-
Clinical Presentation Cerebral Amyloid Angiopathy (CAA) typically presents in older adults, often over the age …
-
Headaches
Clinical Management and Outcomes of Dengue Fever and Enteric Fever
by myneuronewsby myneuronewsClinical Characteristics of Dengue and Enteric Fever Dengue fever and enteric fever are two distinct …
-
Headaches
Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity
by myneuronewsby myneuronewsEffects of Ergotamine on Circadian Rhythm Recent investigations have illuminated the role of ergotamine in …
-
Headaches
Clinical characteristics and efficacy of intrathecal therapy in pediatric lupus encephalopathy
by myneuronewsby myneuronewsClinical Presentation and Diagnosis Pediatric lupus encephalopathy, often associated with systemic lupus erythematosus (SLE), manifests …
-
Headaches
Long-term safety and tolerability of zavegepant 10-mg nasal spray with concomitant use of anti-calcitonin gene-related peptide monoclonal antibodies or other select preventive migraine medications: Results from a phase 2/3 open-label study
by myneuronewsby myneuronewsStudy Overview This phase 2/3 open-label study was designed to evaluate the long-term safety and …
-
Headaches
Raising the bar in migraine prevention: Toward freedom and optimal control
by myneuronewsby myneuronewsCurrent Approaches to Migraine Prevention Migraine prevention encompasses a variety of methodologies aimed at reducing …